Chronic administration of oil palm (Elaeis guineensis) leaves extract attenuates hyperglycaemic-induced oxidative stress and improves renal histopathology and function in experimental diabetes

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Rajavel, Varatharajan ^a   Abdul Sattar, Munavvar Zubaid ^b   Abdulla, Mahmood Ameen ^a   Kassim, Normadiah M ^a   Abdullah, Nor Azizan ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANTIOXIDANT; ELAEIS GUINEENSIS EXTRACT; GLUCOSE; GLUTATHIONE; LIPID PEROXIDE; PLANT EXTRACT; PROTEIN; SODIUM; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFICACY; ELAEIS GUINEENSIS; EXPERIMENTAL DIABETES MELLITUS; GLOMERULOSCLEROSIS; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERGLYCEMIA; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY MASS; MALE; METABOLIC PARAMETERS; NONHUMAN; OXIDATIVE STRESS; PLANT LEAF; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PROTEINURIA; RAT; RENAL PROTECTION; SODIUM URINE LEVEL; STREPTOZOCIN DIABETES; URINE FLOW RATE; WEIGHT REDUCTION;

EID: 84871435254     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/195367     Document Type: Article

References (60)

1. Mogensen C. E., Christensen C. K., Vittinghus E., The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983 32 supplement 2 64 78 2-s2.0-0020529948 (Pubitemid 13099685)
2. Dronavalli S., Duka I., Bakris G. L., The pathogenesis of diabetic nephropathy. Nature Clinical Practice Endocrinology and Metabolism 2008 4 8 444 452 2-s2.0-47949127622 10.1038/ncpendmet0894
3. Shamoon H., Duffy H., Fleischer N., Engel S., Saenger P., Strelzyn M., Litwak M., Wylie-Rosett J., Farkash A., Geiger D., Engel H., Fleischman J., Pompi D., Ginsberg N., Glover M., Brisman M., Walker E., Thomashunis A., Gonzalez J., The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine 1993 329 14 977 986 2-s2.0-0028285233 10.1056/NEJM199309303291401 (Pubitemid 23307905)
4. Turner R., Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet 1998 352 9131 837 853 2-s2.0-0032511583 10.1016/S0140-6736(98)07019-6 (Pubitemid 28416718)
5. Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S., Kojima Y., Furuyoshi N., Shichiri M., Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Research and Clinical Practice 1995 28 2 103 117 2-s2.0-0029147687 10.1016/0168-8227(95)01064-K
6. Hostetter T. H., Hypertrophy and hyperfunction of the diabetic kidney. The Journal of Clinical Investigation 2001 107 2 161 162 2-s2.0-0035139808 (Pubitemid 32096831)
7. Navarro-González J. F., Mora-Fernández C., The role of inflammatory cytokines in diabetic nephropathy. Journal of the American Society of Nephrology 2008 19 3 433 442 2-s2.0-40449113524 10.1681/ASN.2007091048 (Pubitemid 351355386)
8. Nishikawa T., Edelstein D., Du X. L., Yamagishi S. I., Matsumura T., Kaneda Y., Yorek M. A., Beebe D., Oates P. J., Hammes H. P., Glardino I., Brownlee M., Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000 404 6779 787 790 2-s2.0-0034643340 10.1038/35008121 (Pubitemid 30212409)
9. Brownlee M., Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 6865 813 820 2-s2.0-0035856980 10.1038/414813a (Pubitemid 34000785)
10. Giacco F., Brownlee M., Oxidative stress and diabetic complications. Circulation Research 2010 107 9 1058 1070 2-s2.0-78349297565 10.1161/CIRCRESAHA.110.223545
11. Forbes J. M., Coughlan M. T., Cooper M. E., Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008 57 6 1446 1454 2-s2.0-48249085391 10.2337/db08-0057
12. Eun A. L., Ji Y. S., Jiang Z., Mi R. Y., Min K. K., Ha H., Hi B. L., Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney. Kidney International 2005 67 5 1762 1771 2-s2.0-17744377972 10.1111/j.1523-1755.2005. 00274.x (Pubitemid 40577711)
13. Halliwell B., Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs and Aging 2001 18 9 685 716 2-s2.0-0034796353 (Pubitemid 32948277)
14. Lee H. B., Yu M. R., Yang Y., Jiang Z., Ha H., Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. Journal of the American Society of Nephrology 2003 14 3 S241 S245 2-s2.0-0042867408 (Pubitemid 36903933)
15. Kanwar Y. S., Wada J., Sun L., Xie P., Wallner E. I., Chen S., Chugh S., Danesh F. R., Diabetic nephropathy: mechanisms of renal disease progression. Experimental Biology and Medicine 2008 233 1 4 11 2-s2.0-37549035027 10.3181/0705-MR-134
16. Mustata G. T., Rosca M., Biemel K. M., Reihl O., Smith M. A., Viswanathan A., Strauch C., Du Y., Tang J., Kern T. S., Lederer M. O., Brownlee M., Weiss M. F., Monnier V. M., Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking. Diabetes 2005 54 2 517 526 2-s2.0-19944432813 10.2337/diabetes.54.2.517
17. Mann J. F. E., Lonn E. M., Yi Q., Gerstein H. C., Hoogwerf B. J., Pogue J., Bosch J., Dagenais G. R., Yusuf S., Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE Study. Kidney International 2004 65 4 1375 1380 2-s2.0-1642422335 10.1111/j.1523-1755.2004.00513.x (Pubitemid 38406976)
18. Vignini A., Alidori A., Montesi L., Raffaelli F., Nanetti L., Bertoli E., Mazzanti L., Vitamin E, diabetes and related diseases: an update. Mediterranean Journal of Nutrition and Metabolism 2011 4 1 3 9 2-s2.0-79954590726 10.1007/s12349-010-0006-y
19. Jaffri J. M., Mohamed S., Rohimi N., Ahmad I. N., Noordin M. M., Manap Y. A., Antihypertensive and cardiovascular effects of catechin-rich oil palm (Elaeis guineensis) leaf extract in nitric oxide-deficient rats. Journal of Medicinal Food 2011 14 7-8 775 783 2-s2.0-79955574723 10.1089/jmf.2010.1170
20. Khan N., Mukhtar H., Tea polyphenols for health promotion. Life Sciences 2007 81 7 519 533 2-s2.0-34547679576 10.1016/j.lfs.2007.06.011 (Pubitemid 47212236)
21. Rosalina Tan R. T., Mohamed S., Samaneh G. F., Noordin M. M., Goh Y. M., Manap M. Y. A., Polyphenol rich oil palm leaves extract reduce hyperglycaemia and lipid oxidation in STZ-rats. International Food Research Journal 2011 18 1 179 188 2-s2.0-78449265581
22. Doumas B. T., Bayse D. D., Carter R. J., Peters T. Jr., Schaffer R., A candidate Reference Method for determination of total protein in serum. I. Development and validation. Clinical Chemistry 1981 27 10 1642 1650 2-s2.0-0019493610 (Pubitemid 11016124)
23. Somogyi M., A method for the preparation of blood filtrates for the determination of sugar. The Journal of Biological Chemistry 1930 86 655 663
24. Bojesen E., A method for determination of inulin in plasma and urine. Acta Medica Scandinavica. Supplementum 1952 266 275 282 2-s2.0-76949138646
25. Saito T., Sumithran E., Glasgow E. F., Atkins R. C., The enhancement of aminonucleoside nephrosis by the co-administration of protamine. Kidney International 1987 32 5 691 699 2-s2.0-0023637202 (Pubitemid 17152399)
26. Taneda S., Pippin J. W., Sage E. H., Hudkins K. L., Takeuchi Y., Couser W. G., Alpers C. E., Amelioration of diabetic nephropathy in SPARC-null mice. Journal of the American Society of Nephrology 2003 14 4 968 980 2-s2.0-0037378070 10.1097/01.ASN.0000054498.83125.90 (Pubitemid 36359278)
27. Runnie I., Mustapha N. M., Musec R., Hamid A., Nawawi H., Abeywardenae M. Y., Mohamed S., Antioxidant and hypercholesterolemic effects of Elaies guineensis fond extract on hypercholesterolemic rats. ASEAN Food Journal 2003 3 137 148
28. Jaffri J. M., Mohamed S., Ahmad I. N., Mustapha N. M., Manap Y. A., Rohimi N., Effects of catechin-rich oil palm leaf extract on normal and hypertensive rats' kidney and liver. Food Chemistry 2011 128 2 433 441 2-s2.0-79955608849 10.1016/j.foodchem.2011.03.050
29. Hostetter T. H., Troy J. L., Brenner B. M., Glomerular hemodynamics in experimental diabetes mellitus. Kidney International 1981 19 3 410 415 2-s2.0-0019460233 (Pubitemid 11112621)
30. Veelken R., Hilgers K. F., Hartner A., Haas A., Böhmer K. P., Sterzel R. B., Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. Journal of the American Society of Nephrology 2000 11 1 71 79 2-s2.0-0033982133 (Pubitemid 30020428)
31. Komers R., Allen T. J., Cooper M. E., Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes 1994 43 10 1190 1197 2-s2.0-0028117041 (Pubitemid 24361183)
32. Komers R., Lindsley J. N., Oyama T. T., Schutzer W. E., Reed J. F., Mader S. L., Anderson S., Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes. The Journal of Clinical Investigation 2001 107 7 889 898 2-s2.0-0035057565 (Pubitemid 32274042)
33. Li J., Chen Y. J., Quilley J., Effect of tempol on renal cyclooxygenase expression and activity in experimental diabetes in the rat. Journal of Pharmacology and Experimental Therapeutics 2005 314 2 818 824 2-s2.0-22944493029 10.1124/jpet.104.076927 (Pubitemid 41043867)
34. Chen Y. J., Li J., Quilley J., Effect of inhibition of nitric oxide synthase on renal cyclooxygenase in the diabetic rat. European Journal of Pharmacology 2006 541 1-2 80 86 2-s2.0-33745127752 10.1016/j.ejphar.2006.05.004 (Pubitemid 43903477)
35. Koya D., Lee I. K., Ishii H., Kanoh H., King G. L., Prevention of glomerullar dysfunction in diabetic rats by treatment with d- α -tocopherol. Journal of the American Society of Nephrology 1997 8 3 426 435 2-s2.0-0031093983 (Pubitemid 127454178)
36. Melhem M. F., Craven P. A., DeRubertis F. R., Effects of dietary supplementation of α -Lipoic acid on early glomerular injury in diabetes mellitus. Journal of the American Society of Nephrology 2001 12 1 124 133 2-s2.0-0035174786 (Pubitemid 32056797)
37. Su J., Zhang P., Zhang J. J., Qi X. M., Wu Y. G., Shen J. J., Effects of total glucosides of paeony on oxidative stress in the kidney from diabetic rats. Phytomedicine 2010 17 3-4 254 260 2-s2.0-75249104928 10.1016/j.phymed.2009.07. 005
38. Satoh M., Fujimoto S., Haruna Y., Arakawa S., Horike H., Komai N., Sasaki T., Tsujioka K., Makino H., Kashihara N., NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. American Journal of Physiology 2005 288 6 F1144 F1152 2-s2.0-21044436751 10.1152/ajprenal.00221.2004 (Pubitemid 40677084)
39. Susztak K., Raff A. C., Schiffer M., Böttinger E. P., Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006 55 1 225 233 2-s2.0-33644783770 10.2337/diabetes.55.1.225 (Pubitemid 43343319)
40. Kashihara N., Watanabe Y., Makino H., Wallner E. I., Kanwar Y. S., Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species. Proceedings of the National Academy of Sciences of the United States of America 1992 89 14 6309 6313 2-s2.0-0026680435 10.1073/pnas.89.14.6309
41. Vink H., Duling B. R., Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circulation Research 1996 79 3 581 589 2-s2.0-0029797605 (Pubitemid 26276918)
42. DeRubertis F. R., Craven P. A., Melhem M. F., Salah E. M., Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction. Diabetes 2004 53 3 762 768 2-s2.0-1442349987 10.2337/diabetes.53.3.762 (Pubitemid 38270647)
43. Spurney R. F., Coffman T. M., Stressed-out podocytes in diabetes? Journal of the American Society of Nephrology 2008 19 11 2035 2037 2-s2.0-55749108183 10.1681/ASN.2008090955
44. Zheng S., Carlson E. C., Yang L., Kralik P. M., Huang Y., Epstein P. N., Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy. Journal of the American Society of Nephrology 2008 19 11 2077 2085 2-s2.0-55749110018 10.1681/ASN.2007080967
45. Yamabe N., Yokozawa T., Oya T., Kim M., Therapeutic potential of (-)-epigallocatechin 3- O -gallate on renal damage in diabetic nephropathy model rats. Journal of Pharmacology and Experimental Therapeutics 2006 319 1 228 236 2-s2.0-33749011205 10.1124/jpet.106.107029 (Pubitemid 44455127)
46. Bhatti F., Mankhey R. W., Asico L., Quinn M. T., Welch W. J., Maric C., Mechanisms of antioxidant and pro-oxidant effects of α -lipoic acid in the diabetic and nondiabetic kidney. Kidney International 2005 67 4 1371 1380 2-s2.0-16244413938 10.1111/j.1523-1755.2005.00214.x (Pubitemid 40463113)
47. Kataya H. A. H., Hamza A. A., Red cabbage (Brassica oleracea) ameliorates diabetic nephropathy in rats. Evidence-Based Complementary and Alternative Medicine 2008 5 3 281 287 2-s2.0-51849127444 10.1093/ecam/nem029
48. Mason R. M., Wahab N. A., Extracellular matrix metabolism in diabetic nephropathy. Journal of the American Society of Nephrology 2003 14 5 1358 1373 2-s2.0-0037407520 10.1097/01.ASN.0000065640.77499.D7 (Pubitemid 36519197)
49. Craven P. A., Derubertis F. R., Kagan V. E., Melhem M., Studer R. K., Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF- β and glomerular size in diabetes. Journal of the American Society of Nephrology 1997 8 9 1405 1414 2-s2.0-0030784837
50. Ha H., Hi Bahl Lee, Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney International, Supplement 2000 58 77 S19 S25 2-s2.0-0033851574
51. Iglesias-De La Cruz M. C., Ruiz-Torres P., Alcamí J., Díez-Marqués L., Ortega-Velázquez R., Chen S., Rodríguez-Puyol M., Ziyadeh F. N., Rodríguez-Puyol D., Hydrogen peroxide increases extracellular matrix mRNA through TGF- β in human mesangial cells. Kidney International 2001 59 1 87 95 2-s2.0-0035171881 10.1046/j.1523-1755.2001.00469.x (Pubitemid 32055217)
52. Studer R. K., Craven P. A., DeRubertis F. R., Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells. Metabolism 1997 46 8 918 925 2-s2.0-0030838053 10.1016/S0026-0495(97)90080-9 (Pubitemid 27339917)
53. Ha H., Lee S. H., Kim K. H., Effects of rebamipide in a model of experimental diabetes and on the synthesis of transforming growth factor- β and fibronectin, and lipid peroxidation induced by high glucose in cultured mesangial cells. Journal of Pharmacology and Experimental Therapeutics 1997 281 3 1457 1462 2-s2.0-0030972189 (Pubitemid 27258407)
54. Peixoto E. B. M. I., Pessoa B. S., Biswas S. K., Lopes De Faria J. B., Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension. American Journal of Nephrology 2009 29 4 309 318 2-s2.0-53449089230 10.1159/000163767
55. Li H., Wang F., Zhang L., Cao Y., Liu W., Hao J., Liu Q., Duan H., Modulation of Nrf2 expression alters high glucose-induced oxidative stress and antioxidant gene expression in mouse mesangial cells. Cellular Signalling 2011 23 10 1625 1632 2-s2.0-79960721951 10.1016/j.cellsig.2011.05.016
56. Ha H., Kim K. H., Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C. Diabetes Research and Clinical Practice 1999 45 2-3 147 151 2-s2.0-0344548772 10.1016/S0168-8227(99)00044-3 (Pubitemid 29457762)
57. Obrosova I. G., Fathallah L., Liu E., Nourooz-Zadeh J., Early oxidative stress in the diabetic kidney: effect of DL- α -lipoic acid. Free Radical Biology and Medicine 2003 34 2 186 195 2-s2.0-0037438946 10.1016/S0891-5849(02) 01195-4 (Pubitemid 36084322)
58. Sugimoto K. I., Tsuruoka S., Fujimura A., Effect of enalapril on diabetic nephropathy in OLETF rats: the role of an anti-oxidative action in its protective properties. Clinical and Experimental Pharmacology and Physiology 2001 28 10 826 830 2-s2.0-0034784060 10.1046/j.1440-1681.2001.03530.x (Pubitemid 32947179)
59. Van Dam P. S., Bravenboer B., Van Asbeck B. S., Van Oirschot J. F. L. M., Marx J. J. M., Gispen W. H., Effects of insulin treatment on endoneurial and systemic oxidative stress in relation to nerve conduction in streptozotocin-diabetic rats. European The Journal of Clinical Investigation 1996 26 12 1143 1149 2-s2.0-0030456320 (Pubitemid 27023532)
60. Kakimoto M., Inoguchi T., Sonta T., Yu H. Y., Imamura M., Etoh T., Hashimoto T., Nawata H., Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats. Diabetes 2002 51 5 1588 1595 2-s2.0-0036317040 (Pubitemid 34826629)